Lp(a) Lipoprotein Is an Independent, Discriminating Risk Factor for Premature Peripheral Atherosclerosis Among White Men

R. James Valentine, Paul A. Grayburn, Gloria L Vega, Scott M Grundy

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Background: Elevated plasma levels of Lp(a) lipoprotein have been linked to the development of premature atherosclerosis in the coronary circulation (coronary artery disease [CAD]). Although Lp(a) lipoprotein has been implicated as a risk factor for premature atherosclerosis in other locations, the patient populations described were not carefully screened for the coexistence of premature CAD. The purpose of this prospective study was to determine whether carefully screened patients with premature peripheral vascular disease (PVD) have elevated plasma levels of Lp(a) lipoprotein and to test the relative strength of Lp(a) lipoprotein level as a risk factor for premature PVD. Methods: We studied 55 consecutive white men with premature PVD (onset at 45 years of age or earlier) presenting to our vascular laboratory. Study subjects were substratified into 17 with PVD only and 38 with combined PVD and CAD (PVD + CAD). Two comparison groups included 26 age-matched white men with premature CAD recruited from the Cardiology Service after cardiac catheterization and 32 age-matched white male controls recruited from outpatient clinics. Results: Mean plasma apolipoprotein B-100 levels were higher in the CAD group than in controls (P=.013). Mean plasma Lp(a) lipoprotein levels were higher among the 17 patients with PVD only than among controls (P=.008). The covariance-adjusted mean Lp(a) lipoprotein levels were higher among all 55 patients with PVD than among controls (P=.014). Logistic regression analysis demonstrated two variables to be significantly related to premature PVD: Lp(a) lipoprotein level greater than 30 mg/dL (odds ratio, 3.9; 95% confidence interval, 1.1 to 13.7) and apolipoprotein B level greater than 95 mg/dL (odds ratio, 3.2; 95% confidence interval, 1.0 to 10.0). Conclusions: Lp(a) lipoprotein level is an independent, discriminating risk factor for premature PVD among white men.

Original languageEnglish (US)
Pages (from-to)801-806
Number of pages6
JournalArchives of Internal Medicine
Volume154
Issue number7
DOIs
StatePublished - Apr 11 1994

Fingerprint

Peripheral Vascular Diseases
Lipoproteins
Atherosclerosis
Coronary Artery Disease
Odds Ratio
Confidence Intervals
Apolipoprotein B-100
Coronary Circulation
Apolipoproteins B
Cardiac Catheterization
Ambulatory Care Facilities
Cardiology
Blood Vessels
Logistic Models
Regression Analysis
Prospective Studies
Control Groups

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Lp(a) Lipoprotein Is an Independent, Discriminating Risk Factor for Premature Peripheral Atherosclerosis Among White Men. / Valentine, R. James; Grayburn, Paul A.; Vega, Gloria L; Grundy, Scott M.

In: Archives of Internal Medicine, Vol. 154, No. 7, 11.04.1994, p. 801-806.

Research output: Contribution to journalArticle

@article{38e1530920164f93b3a8d7ba4ed02673,
title = "Lp(a) Lipoprotein Is an Independent, Discriminating Risk Factor for Premature Peripheral Atherosclerosis Among White Men",
abstract = "Background: Elevated plasma levels of Lp(a) lipoprotein have been linked to the development of premature atherosclerosis in the coronary circulation (coronary artery disease [CAD]). Although Lp(a) lipoprotein has been implicated as a risk factor for premature atherosclerosis in other locations, the patient populations described were not carefully screened for the coexistence of premature CAD. The purpose of this prospective study was to determine whether carefully screened patients with premature peripheral vascular disease (PVD) have elevated plasma levels of Lp(a) lipoprotein and to test the relative strength of Lp(a) lipoprotein level as a risk factor for premature PVD. Methods: We studied 55 consecutive white men with premature PVD (onset at 45 years of age or earlier) presenting to our vascular laboratory. Study subjects were substratified into 17 with PVD only and 38 with combined PVD and CAD (PVD + CAD). Two comparison groups included 26 age-matched white men with premature CAD recruited from the Cardiology Service after cardiac catheterization and 32 age-matched white male controls recruited from outpatient clinics. Results: Mean plasma apolipoprotein B-100 levels were higher in the CAD group than in controls (P=.013). Mean plasma Lp(a) lipoprotein levels were higher among the 17 patients with PVD only than among controls (P=.008). The covariance-adjusted mean Lp(a) lipoprotein levels were higher among all 55 patients with PVD than among controls (P=.014). Logistic regression analysis demonstrated two variables to be significantly related to premature PVD: Lp(a) lipoprotein level greater than 30 mg/dL (odds ratio, 3.9; 95{\%} confidence interval, 1.1 to 13.7) and apolipoprotein B level greater than 95 mg/dL (odds ratio, 3.2; 95{\%} confidence interval, 1.0 to 10.0). Conclusions: Lp(a) lipoprotein level is an independent, discriminating risk factor for premature PVD among white men.",
author = "Valentine, {R. James} and Grayburn, {Paul A.} and Vega, {Gloria L} and Grundy, {Scott M}",
year = "1994",
month = "4",
day = "11",
doi = "10.1001/archinte.1994.00420070129015",
language = "English (US)",
volume = "154",
pages = "801--806",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Lp(a) Lipoprotein Is an Independent, Discriminating Risk Factor for Premature Peripheral Atherosclerosis Among White Men

AU - Valentine, R. James

AU - Grayburn, Paul A.

AU - Vega, Gloria L

AU - Grundy, Scott M

PY - 1994/4/11

Y1 - 1994/4/11

N2 - Background: Elevated plasma levels of Lp(a) lipoprotein have been linked to the development of premature atherosclerosis in the coronary circulation (coronary artery disease [CAD]). Although Lp(a) lipoprotein has been implicated as a risk factor for premature atherosclerosis in other locations, the patient populations described were not carefully screened for the coexistence of premature CAD. The purpose of this prospective study was to determine whether carefully screened patients with premature peripheral vascular disease (PVD) have elevated plasma levels of Lp(a) lipoprotein and to test the relative strength of Lp(a) lipoprotein level as a risk factor for premature PVD. Methods: We studied 55 consecutive white men with premature PVD (onset at 45 years of age or earlier) presenting to our vascular laboratory. Study subjects were substratified into 17 with PVD only and 38 with combined PVD and CAD (PVD + CAD). Two comparison groups included 26 age-matched white men with premature CAD recruited from the Cardiology Service after cardiac catheterization and 32 age-matched white male controls recruited from outpatient clinics. Results: Mean plasma apolipoprotein B-100 levels were higher in the CAD group than in controls (P=.013). Mean plasma Lp(a) lipoprotein levels were higher among the 17 patients with PVD only than among controls (P=.008). The covariance-adjusted mean Lp(a) lipoprotein levels were higher among all 55 patients with PVD than among controls (P=.014). Logistic regression analysis demonstrated two variables to be significantly related to premature PVD: Lp(a) lipoprotein level greater than 30 mg/dL (odds ratio, 3.9; 95% confidence interval, 1.1 to 13.7) and apolipoprotein B level greater than 95 mg/dL (odds ratio, 3.2; 95% confidence interval, 1.0 to 10.0). Conclusions: Lp(a) lipoprotein level is an independent, discriminating risk factor for premature PVD among white men.

AB - Background: Elevated plasma levels of Lp(a) lipoprotein have been linked to the development of premature atherosclerosis in the coronary circulation (coronary artery disease [CAD]). Although Lp(a) lipoprotein has been implicated as a risk factor for premature atherosclerosis in other locations, the patient populations described were not carefully screened for the coexistence of premature CAD. The purpose of this prospective study was to determine whether carefully screened patients with premature peripheral vascular disease (PVD) have elevated plasma levels of Lp(a) lipoprotein and to test the relative strength of Lp(a) lipoprotein level as a risk factor for premature PVD. Methods: We studied 55 consecutive white men with premature PVD (onset at 45 years of age or earlier) presenting to our vascular laboratory. Study subjects were substratified into 17 with PVD only and 38 with combined PVD and CAD (PVD + CAD). Two comparison groups included 26 age-matched white men with premature CAD recruited from the Cardiology Service after cardiac catheterization and 32 age-matched white male controls recruited from outpatient clinics. Results: Mean plasma apolipoprotein B-100 levels were higher in the CAD group than in controls (P=.013). Mean plasma Lp(a) lipoprotein levels were higher among the 17 patients with PVD only than among controls (P=.008). The covariance-adjusted mean Lp(a) lipoprotein levels were higher among all 55 patients with PVD than among controls (P=.014). Logistic regression analysis demonstrated two variables to be significantly related to premature PVD: Lp(a) lipoprotein level greater than 30 mg/dL (odds ratio, 3.9; 95% confidence interval, 1.1 to 13.7) and apolipoprotein B level greater than 95 mg/dL (odds ratio, 3.2; 95% confidence interval, 1.0 to 10.0). Conclusions: Lp(a) lipoprotein level is an independent, discriminating risk factor for premature PVD among white men.

UR - http://www.scopus.com/inward/record.url?scp=84942480790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942480790&partnerID=8YFLogxK

U2 - 10.1001/archinte.1994.00420070129015

DO - 10.1001/archinte.1994.00420070129015

M3 - Article

C2 - 8147686

AN - SCOPUS:84942480790

VL - 154

SP - 801

EP - 806

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 7

ER -